GC Quantification of Cyclopropylamine, Diethylamine and Triethylamine in Active Pharmaceutical Ingredients
Full Short Communication
First Online:
Received:
Revised:
Accepted:
- 382 Downloads
- 2 Citations
Abstract
Gas chromatography with headspace injection technique has been developed for the quantification of diethylamine, triethylamine and cyclopropylamine in active pharmaceutical ingredients. The chromatographic separation is achieved on dimethylpolysiloxane oil coated capillary column with flame ionization detector. GC run time was 15 min employing programmed temperature with split mode headspace injection. The method is validated for specificity, linearity, accuracy, precision, and robustness.
Keywords
Gas chromatography Head space injection AminesNotes
Acknowledgments
The authors wish to thank the management of Hetero Labs Limited for supporting this work and Dr. D.V. Subbarao of Versapharm Inc USA.
References
- 1.ICH (2007) Impurities: Guideline for Residual Solvents Q3C(R4) International conference on harmonizationGoogle Scholar
- 2.United States Pharmacopeia (2009), USP31/NF26 - General chapter < 467 > Residual SolventsGoogle Scholar
- 3.European Pharmacopeia. (2007) 6.0 Identification and control of residual solvents 2.4.24, Residual solvents 5.4Google Scholar
- 4.Center for Drug Evaluation and Research (CDER) (2009) Guidance on Residual solvents in the drug products marketed in the united states Food and Drug AdministrationGoogle Scholar
- 5.EDQM Europe (2007), Content of the dossier for chemical purity and microbial quality, PA/PH/CEP (04) 1 4RGoogle Scholar
- 6.Subbarao DV, Radhakrishnanand P, Suryanarayana MV, Himabindu V (2007) J. Chromatographia 66:499–507CrossRefGoogle Scholar
- 7.Subbarao DV, Radhakrishnanand P, Himabindu V (2008) J. Chromatographia 67:183–188CrossRefGoogle Scholar
- 8.Subbarao DV, Surendranath KV, Radhakrishnanand P, Suryanarayana MV, Raghuram P (2008) J Chromatographia 68:829–835CrossRefGoogle Scholar
- 9.Kataoka Hiroyuki (2005) J Chromatogr Libr 70:364–404Google Scholar
- 10.Dalene M, Skarping G (1985) J Chromatogr A 331:321–330CrossRefGoogle Scholar
- 11.Kataoka H, Shindoh S, Makita M (1995) J Chromatogr A 695:142–148CrossRefGoogle Scholar
- 12.Billiet HAH (1992) J Chromatogr Libr 51:B583–B595CrossRefGoogle Scholar
- 13.Sacher F, Lenz S, Brauch H-J (1997) J Chromatogr A 764:85–93CrossRefGoogle Scholar
- 14.Namieśnik J, Zygmunt B (2005) J Chromatogr Libr 70:340–363Google Scholar
- 15.Kataoka H (1996) J Chromatogr A 733:19–34CrossRefGoogle Scholar
- 16.Maris C, Laplanche A, Morvan J, Bloquelnal M (1999) J Chromatogr A 846:331–339CrossRefGoogle Scholar
- 17.
- 18.
- 19.ICH (2007) Q3A(R2): Impurities in New Drug Substances GuidanceGoogle Scholar
- 20.ICH (2007) Q2(R1) Validation of Analytical Procedures: Text and Methodology GuidanceGoogle Scholar
- 21.United States Pharmacopeia (2009), 31 NF 26:General chapter < 1225 > Validation of compendial proceduresGoogle Scholar
- 22.Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER) (2000), Analytical Procedures and Methods Validation Chemistry, Manufacturing, and Controls Documentation, Draft Guidance U.S. Food and Drug AdministrationGoogle Scholar
- 23.EURACHEM, The Fitness for Purpose of Analytical Methods- A Laboratory Guide to Method Validation and Related Topics GuidanceGoogle Scholar
- 24.Center for Drug Evaluation and Research (CDER) (1994),Reviewer Guidance Validation of Chromatographic MethodsGoogle Scholar
- 25.EDQM (2005) Validation of Analytical Procedures PA/PH/OMCL (05) 47 DEF, OMCL (Office of medicinal Control Laboratories) NetworkGoogle Scholar
- 26.ORA LABORATORY PROCEDURE (2009) Methods, Method Verification and Validation - Food and Drug Administration-Document No.: ORA-LAB.5.4.5Google Scholar
Copyright information
© Vieweg+Teubner Verlag | Springer Fachmedien Wiesbaden GmbH 2010